All Episodes

Critical Items to Consider When Bringing Your Medtech Startup to the US | LSI Asia '25

Ask the Experts: Globalization Strategy and Partnership Readiness | LSI Asia '25

Borderless Data: Why One Size Doesn’t Fit All | LSI Asia '25

Building and Scaling Successful Medtech Ventures from Singapore | LSI Asia '25

Invisible Risk: Cybersecurity Mistakes That Stall Market Momentum | LSI Asia '25

IP Goldmine or Landmine? Investor-Ready IP Strategies | LSI Asia '25

Telling Your Story to Early-Stage Investors | LSI Asia '25

Sourcing Innovation: Can Medtech Replicate Biotech’s Asia Playbook? | LSI Asia '25

Why We Said No: Lessons from the Investments Family Offices Didn’t Make | LSI Asia '25

The Future of Longer, Healthier Lives | LSI Asia '25

The Australia Advantage: Smart Capital Strategies in a Shifting Global Market | LSI Asia '25

The Aging Brain: Challenges and Opportunities in Neurodegeneration and Neurotrauma | LSI Asia '25

Strategy and Commercial Infrastructure Needed to Scale Medtech in the U.S. | LSI Asia '25

Singapore’s Unique Approach to Fostering and Backing Healthcare Innovation | LSI Asia '25

Signature Series: What's Holding Asia Back in Medtech | LSI Asia '25

Signature Series: The Archipelago of Innovation: Navigating Japan’s Startup Landscape | LSI Asia '25

Signature Series: More than Manufacturing — Developing Integrated R&D, Supply Chain, and Innovation in APAC | LSI Asia '25

Signature Series: Can Asia Produce a Medtech Unicorn? | LSI Asia '25

Scaling Diagnostics: From Innovation to Infrastructure | LSI Asia '25

Redefining the Global Standard of Care in Maternal & Fetal Health | LSI Asia '25

Reaching Across Borders: Multinational Corporate Investment and Collaboration in t... | LSI Asia '25

New Era: Finding The Right Place for APAC Within The Startup Strategy | LSIAsia '25

M&A and Partnerships: How Strategics Approach Asia | LSI Asia '25

Keynote: Unlocking APAC's Medtech Potential — A Gateway to Global Success | LSI Asia '25

Keynote: Touchpoints that Matter: Building Health Systems for the Next Billion Patients | Asia '25

How to Engage Clinicians as Investors in Medtech Ventures | LSI Asia '25

Get on the Plane: Why the Best Returns Require the Trip | LSI Asia '25

From Scalpel to Software: Reimagining the Surgical Suite | LSI Asia '25

From Pitch to Partnership: Engaging Investors for Capital and Growth | LSI Asia '25

From Local Insights to Global Impact: Advancing Medtech in Asia Pacific | LSI Asia '25

Fireside Chat: Realizing Asia-Pacific’s Promise Through Talent | LSI Asia '25

Fireside Chat: Hard-Learned Secrets of Thinking Big in Asia | LSI Asia '25

East Meets West | LSI Asia '25

Co-Founding Capital: How Investors Are Shaping the Next Generation of Startups | LSI Asia '25

Bridging the Gap: Equity and Innovation in Patient Reach | LSI Asia '25

Bio-Convergence — The Future of Vision Tech | LSI Asia ‘25

Anchored in Asia, Wired to the World: Singapore’s Innovation Story | LSI Asia '25

The AI Business-Building Era — Unlocking New Levels of Speed in Product Development, GTM, and More | LSI USA '25

The 3 Trends Driving Cardiovascular Investment, M&A, and Deals in 2025+ | LSI USA '25

Staying Sexy Without GenAI or Saas—Buiding Deceptively-Simple, but Brilliant Products | LSI USA '25

Soft Tissue Robotics — Open Architecture or Closed System? The Road Forward | LSI USA '25

Signature Series: Unpacking Stryker's Acquisition of Artelon | LSI USA '25

Signature Series: Unlocking the Potential of Device-Based Hypertension Therapies and Partnerships — 1 on 1 with David Hochman and Chris Eso | LSI USA '25

Signature Series: The Future of Wearables in Cardiac Care | LSI USA '25

Signature Series: Scaling Robotics Beyond Singularly Focused Procedures | LSI USA '25

Signature Series: No Corporate Slides. Real Strategies and Resources to Deliver AI | LSI USA '25

Signature Series: Medtech is Broken. What Changes Will Make the Next 100 Years a Su... | LSI USA '25

Signature Series: Current Market Perspectives from Shifamed and Novo Holdings | LSI USA '25

Signature Series: Building & Exiting Companies in Medtech's Post Covid Financial Era | LSI USA '25

Signature Series: 1 on 1 with David R. Amerson, Former President and CEO of Neotract | LSI USA '25

Signature Series: To Build or To Buy? Stryker's Thesis for AI, Robotics, and Growth | LSI USA '25

Runaway Brides: Build-to-Buys at the Altar of Consummation (A Guide to Reinsurance) | LSI USA '25

Pros and Cons of Creative Financing Approaches for Growth in 2025 | LSI USA '25

Perspectives From Strategics — What on Your 2025 M&A, BD, and Corp Dev Agenda? | LSI USA '25

New Era — Build to Buys | LSI USA '25

New Approaches for (Finally) Funding and Solving Unmet Needs in Women's Health | LSI USA '25

Navigating Innovation, Investment, and Impact in 2025 | LSI USA '25

Meeting Unmet Needs in Cardiovascular, Endovascular, and More with Innovation | LSI USA '25

Medtech 2025 — Here Come the Deals | LSI USA '25

Lessons From Startup Nation — How do Roots in Israel Set the Foundation for Success? | LSI USA '25

Keynote with Lisa Earnhardt, Executive Vice President & Group President, Medical Devices at Abbott | LSI USA '25

Keynote w/ Joe Kiani, the Founder, Chairman, CEO of Willow Labs, and Founder of Masimo | LSI USA '25

Keynote w/ Gary S. Guthart, PhD, CEO and Member of the Board of Directors at Intuitive | LSI USA '25

Investors — Do The Best Operators Really Need You? | LSI USA '25

Investing in Cardio in 2025 — What are VCs Considering? | LSI USA '25

Innovation in Financing — How Can Investors Preemptively Remove Financing Risk? | LSI USA '25

How Will AI Revolutionize Image and Cardiovascular Care? | LSI USA '25

How Does Mayo Ventures Collaborate with Industry to Drive Innovation? | LSI USA '25

How Can Medtech Bridge the Philosophical Gap With Big Tech and Big Pharma | LSI USA '25

How Can Clinical, Supplier, and Other Types of Partnerships Make Precision Medicine? | LSI USA '25

Growth Investing in 2025 — Where Will Value Accrue in Later-Stage Medtech? | LSI USA '25

Founder ≠ CEO | LSI USA '25

Fireside Chat: The Viscogliosi Brothers Journey, and What's Next? | LSI USA '25

Fireside Chat: Real World Evidence as Commercial Strategy for Startups and Strategics | LSI USA '25

Fireside Chat: Wellness 3.0, Building and Scaling a Robotics Startup in a New Era | LSI USA '25

Demystifying Corporate Development — Avoid Common Pitfalls and Run a Best Process | LSI USA '25

Data Quality vs. Data Quantity — Getting to Market Fast or Getting to Market Right? | LSI USA '25

Can Everyone Really Win? Deal Making with Strategics, Health Systems, and Investors | LSI USA '25

Beyond Robotics, What's Shaping the Future in Orthopedics? | LSI USA '25